Polydatin-Mediated Inhibition of HSP90α Disrupts NLRP3 Complexes and Alleviates Acute Pancreatitis
2024

Polydatin Helps Treat Acute Pancreatitis by Targeting NLRP3 Inflammasome

publication 10 minutes Evidence: moderate

Author Information

Author(s): Yang Jiashu, Jiao Chenyang, Liu Nannan, Liu Wen, Wang Yueyao, Pan Ying, Kong Lingdong, Guo Wenjie, Xu Qiang

Primary Institution: State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China

Hypothesis

Can polydatin effectively inhibit the NLRP3 inflammasome to alleviate acute pancreatitis?

Conclusion

Polydatin disrupts the NLRP3 inflammasome complex and shows potential as a treatment for acute pancreatitis.

Supporting Evidence

  • Polydatin was found to inhibit the formation of the NLRP3 inflammasome complex.
  • Polydatin treatment led to reduced levels of inflammatory cytokines in animal models.
  • HSP90α was identified as a target of polydatin, crucial for NLRP3 stability.
  • Polydatin showed effectiveness against both wild-type and mutant forms of NLRP3.

Takeaway

Polydatin is a natural compound that can help reduce inflammation in the body by targeting a specific protein complex involved in diseases.

Methodology

The study used various assays to investigate the effects of polydatin on the NLRP3 inflammasome in cell cultures and animal models.

Limitations

The study primarily focused on in vitro and animal models, which may not fully represent human responses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.34133/research.0551

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication